Elisabeth Paramythiotou
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 10
-
- Fungal Infections and Studies 3
- Pneumonia and Respiratory Infections 2
- Co-authors
- Apostolos Armaganidis (9 shared papers)George Dimοpoulos (6 shared papers)Frantzeska Frantzeskaki (4 shared papers)Aikaterini Flevari (2 shared papers)Christina Routsi (2 shared papers)Helen Giamarellou (5 shared papers)Andreas Karabinis (4 shared papers)Antoine Andremont (2 shared papers)
- Journals
- Critical Care (3 papers)International Journal of Antimicrobial Agents (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Antibiotics (2 papers)Eurosurveillance (1 paper)
- Partner nations
- GreeceUnited StatesBelgium
In The Last Decade
Elisabeth Paramythiotou
25 papers receiving 792 citations
Peers
Comparison fields: 5 of 75
- Applied Microbiology and Biotechnology 161
- Molecular Medicine 355
- Critical Care and Intensive Care Medicine 88
- Endocrinology 57
- Pharmacology 173
Countries citing papers authored by Elisabeth Paramythiotou
This map shows the geographic impact of Elisabeth Paramythiotou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Paramythiotou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Paramythiotou more than expected).
Fields of papers citing papers by Elisabeth Paramythiotou
This network shows the impact of papers produced by Elisabeth Paramythiotou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Paramythiotou. The network helps show where Elisabeth Paramythiotou may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisabeth Paramythiotou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 154 | |
| 2 | 2014 | 128 | |
| 3 | 2013 | 93 | |
| 4 | 2009 | 89 | |
| 5 | 2012 | 68 | |
| 6 | 2016 | 50 | |
| 7 | 2014 | 48 | |
| 8 | 2007 | 43 | |
| 9 | 2023 | 27 | |
| 10 | 2017 | 19 | |
| 11 | 2024 | 18 | |
| 12 | 2021 | 18 | |
| 13 | 2011 | 15 | |
| 14 | 2023 | 13 | |
| 15 | 2023 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2012 | 4 | |
| 18 | 2011 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2024 | 2 |
About Elisabeth Paramythiotou
Elisabeth Paramythiotou is a scholar working on Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology, Infectious Diseases and Pharmacology, having authored 26 papers that have together received 816 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Antifungal resistance and susceptibility (5 papers), Nosocomial Infections in ICU (4 papers), Fungal Infections and Studies (3 papers), Hemodynamic Monitoring and Therapy (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (161 citations), Molecular Medicine (355 citations), Critical Care and Intensive Care Medicine (88 citations), Endocrinology (57 citations) and Pharmacology (173 citations). Elisabeth Paramythiotou has collaborated with scholars based in Greece, United States and Belgium. Frequent co-authors include Apostolos Armaganidis, George Dimοpoulos, Frantzeska Frantzeskaki, Aikaterini Flevari, Christina Routsi, Helen Giamarellou, Andreas Karabinis, Antoine Andremont, Anastasia Antoniadou and Stéphanie Belloc. Their work appears in journals such as Critical Care, International Journal of Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, Antibiotics and Eurosurveillance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.